echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System >  Nat Neurosci.: A new direction in the treatment of multiple sclerosis: microglia can remove toxic lipids in multiple sclerosis

     Nat Neurosci.: A new direction in the treatment of multiple sclerosis: microglia can remove toxic lipids in multiple sclerosis

    • Last Update: 2021-05-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Dong and colleagues studied the mechanisms that mediate neurodegeneration in multiple sclerosis and determined the direct role of oxidized phosphatidylcholines (OxPCs) in driving the death of central nerve cells.
    The activity of microglia mediated by lipid sensor TREM2 and neutralizing OxPC antibody can rescue the neurotoxicity induced by OxPC.
    Multiple sclerosis (MS) is an autoimmune disease characterized by demyelination and neurodegenerative processes, including axonal damage, and in the most severe cases, the loss of neurons in the central nervous system.
    This debilitating disease is the main cause of neurological dysfunction in young people, and most cases are diagnosed between the ages of 20-50.
    No genes responsible for multiple sclerosis have been discovered; however, genome-wide association studies have identified more than 200 variants and cells involved in the adaptive and innate immune system.
    The pathological feature of MS is demyelination of the brain or spinal cord, which is invaded by self-reactive adaptive immune cells.
    The broad view regarding the progression of multiple sclerosis is that autoimmune lymphocytes attack and destroy myelin, making oligodendrocytes and axons easy to die, leading to subsequent neurodegeneration, but whether myelin fragments cause neurotoxicity, if Yes, the mechanism involved is unclear.
    Dong et al.
    pointed out in the journal Nature Neuroscience that oxidized phosphatidylcholines (OxPCs) are only present in multiple sclerosis lesions and not in the adjacent normal white matter.
    Prior to this, OxPCs had been reported in MS lesions, but Dong.
    .
    .



    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.